If the chance of viral infection is high in the first 3C6?months after starting alemtuzumab or cladribine, the guideline advises against commencing these drugs during the pandemic, and if a patient is already on these medicines the next round of treatment should be delayed
If the chance of viral infection is high in the first 3C6?months after starting alemtuzumab or cladribine, the guideline advises against commencing these drugs during the pandemic, and if a…